Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Hodgkin Disease 29Lymphoma 27HIV Infections 11Acquired Immunodeficiency Syndrome 10Testicular Neoplasms 9Teratoma 8Lymphoma, Non-Hodgkin 8Testicular Germ Cell Tumor 6Sarcoma, Kaposi 6Lymphoma, Follicular 6Endodermal Sinus Tumor 6Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Carcinoma, Embryonal 5Head and Neck Neoplasms 4Seminoma 3Neoplasm Metastasis 3Teratoma, Testicular 2Squamous Cell Carcinoma of Head and Neck 2Ovarian Germ Cell Cancer 2Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Cardiotoxicity 2Burkitt Lymphoma 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Skin Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion, Malignant 1

Interventions

Paclitaxel 5Etoposide 4Oxaliplatin 3Ifosfamide 3Granulocyte Colony-Stimulating Factor 3Gemcitabine 3Cyclophosphamide 3Cisplatin 3Carboplatin 3ribociclib 2fludarabine 2etoposide phosphate 2Stem Cell Transplantation 2Sirolimus 2Melphalan 2Filgrastim 2Everolimus 2Busulfan 2130-nm albumin-bound paclitaxel 2trametinib 1tozuleristide 1sonidegib 1ripretinib 1pralsetinib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1pazopanib 1olaparib 1interferon gamma-1b 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasms, Germ Cell and Embryonal × Bleomycin × Clear all
NCT02161692 2014-06-12

Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Completed
Genitourinary

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡